The Business Research Company’s 2025 update on the anti-aging drugs market offers a clear picture of growth dynamics. It details how an aging population and novel therapies drive market expansion, exemplified by the forecast from $57.18B to $61.39B. This insight is a prime example of how demographic changes and medical innovations intersect in the pharmaceutical sector.